1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow Fanconi Anemia, Complementation Group N: new trials by email Literature Review of Fanconi Anemia, Complementation Group N trials Research Report on Fanconi Anemia, Complementation Group N
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies DSB2455 - Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency) | Phase 1 | Recruiting | Duke Street Bio Ltd | 180 | 2024-11-21 | 2026-09-02 |
Anophthalmia with pulmonary hypoplasia (1) · Fanconi Anemia, Complementation Group D1 (1)
France (1) · Hungary (1) · Poland (1) · Spain (1) · United States (1)